Three landmark trials confirm that fecal microbiota transplantation is a promising approach to enhancing immunotherapy efficacy in advanced solid tumors. The trials also provide insights with major implications for microbiome therapeutic development.
Sumanta Pal
Get in touch with Sumanta
Contact Sumanta, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack